What if everything you needed to recover from an injury or illness was already residing within your own body? Nina Tandon and her team at EpiBone are trying to make this idea a reality with their mission to harness the body's healing power and develop a new method of skeletal repair. The EpiBone team has figured out how to harness the power of a bioreactor to mimic the conditions found in the human body which enable bone growth. In just three weeks, they are able to build a personalized bone graft out of adult stem cells that is ready for implantation.
With a PhD in tissue engineering and an Executive MBA in healthcare entrepreneurship from Columbia University, Nina has been making waves in both the academic and commercial world with her revolutionary bone growth process. Fast Company named her as one of the top 100 creative people in business and she also is a TED Senior Fellow. In 2017, Nina was also named as a Finalist in Heritage Healthcare's Annual Innovation Awards.
Currently, EpiBone is on track to begin their first human clinical trials this year with a plan of going to market in 2023 if all goes well. We caught up with Nina to learn more about what it has been like to grow her company in New York City and how EpiBone has been received within the medical community.Read More